Tech Company Financing Transactions

Rodin Therapeutics Funding Round

Rodin Therapeutics, operating out of Cambridge, secured $27 million in investment from Atlas Venture, GV and Hatteras Venture Partners.

Transaction Overview

Company Name
Rodin Therapeutics
Announced On
9/20/2017
Transaction Type
Venture Equity
Venture Equity
Amount
$27,000,000
Round
Undisclosed
Investors

Atlas Venture (Bruce Booth)

GV (Ben Robbins)

Hatteras Venture Partners (Clay Thorp)

Remeditex Ventures (John Creecy)

Third Point (Jason Hong)

Proceeds Purpose
This funding is a testament to the strength of our team, and will help accelerate our programs towards clinical trials.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
300 Technology Sq. 8th Floor
Cambridge, MA 02139
USA
Phone
(857) 201-2770
Website
www.rodintherapeutics.com
Email Address
Not Recorded
Overview
Rodin is harnessing the power of epigenetic regulation of neuronal function to treat diseases of the brain. We believe modulation of selective epigenetic regulatory processes can restore synaptic plasticity and cognitive function in degenerative brain diseases, as well as to aid the brain in reducing negative associations with traumatic memories.
Profile
Rodin Therapeutics LinkedIn Company Profile
Social Media
Rodin Therapeutics Company Twitter Account
Company News
Rodin Therapeutics News
Facebook
Rodin Therapeutics on Facebook
YouTube
Rodin Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Bruce Booth
  Bruce Booth LinkedIn Profile  Bruce Booth Twitter Account  Bruce Booth News  Bruce Booth on Facebook
Chairman
Martin Jefson
  Martin Jefson LinkedIn Profile  Martin Jefson Twitter Account  Martin Jefson News  Martin Jefson on Facebook
Chief Executive Officer
Adam Rosenberg
  Adam Rosenberg LinkedIn Profile  Adam Rosenberg Twitter Account  Adam Rosenberg News  Adam Rosenberg on Facebook
Chief Medical Officer
Michael Ryan
  Michael Ryan LinkedIn Profile  Michael Ryan Twitter Account  Michael Ryan News  Michael Ryan on Facebook
Vice President
Magnus Ivarsson
  Magnus Ivarsson LinkedIn Profile  Magnus Ivarsson Twitter Account  Magnus Ivarsson News  Magnus Ivarsson on Facebook
VP - Bus. Development
Anne Sullivan
  Anne Sullivan LinkedIn Profile  Anne Sullivan Twitter Account  Anne Sullivan News  Anne Sullivan on Facebook
VP - Operations
Steven Sweeney
  Steven Sweeney LinkedIn Profile  Steven Sweeney Twitter Account  Steven Sweeney News  Steven Sweeney on Facebook
VP - R & D
Berkley Lynch
  Berkley Lynch LinkedIn Profile  Berkley Lynch Twitter Account  Berkley Lynch News  Berkley Lynch on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/20/2017: 98point6 venture capital transaction
Next: 9/20/2017: The Moms Co venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.